Pette M, Fujita K, Kitze B, Whitaker J N, Albert E, Kappos L, Wekerle H
Clinical Research Unit for Multiple Sclerosis, Max-Planck-Society, Würzburg, West Germany.
Neurology. 1990 Nov;40(11):1770-6. doi: 10.1212/wnl.40.11.1770.
We derived a total of 146 T lymphocyte lines specific for human myelin basic protein (MBP) from the peripheral blood of 20 MS patients and from a control group of 12 healthy donors, and determined the reactivities of T cell lines by [3H]thymidine incorporation on exposure to MBP and MBP peptides 1-44, 45-89, and 90-170. We defined HLA restriction of the T lines by using monoclonal antibodies against monomorphic determinants on human HLA-DR, HLA-DQ, and HLA-DP molecules. MBP-specific T cell lines could be isolated with a comparable efficiency from MS patients and healthy individuals. In both groups, MBP-specific T lymphocytes recognized at least 4 different epitopes in the MBP molecule, and specificities showed comparable patterns for different MBP peptides. MBP-specific T cell lines derived from MS patients and controls were restricted by DR products of the human major histocompatibility class II locus. Notable phenotypic differences of T cell lines existed between the 2 groups. Lines isolated from MS patients expressed predominantly the CD3+ CD4+ CD8- phenotype, while some control lines were composed of up to 87% CD3+CD4+CD8+ T lymphocytes. These findings illustrate the presence of MBP-specific T cells in MS patients and controls that are similarly sensitized to MBP and restricted by HLA-DR products.
我们从20例多发性硬化症(MS)患者的外周血以及12名健康供者组成的对照组中,共获得了146条针对人髓鞘碱性蛋白(MBP)的T淋巴细胞系,并通过在暴露于MBP及MBP肽段1 - 44、45 - 89和90 - 170时掺入[3H]胸腺嘧啶核苷来测定T细胞系的反应性。我们使用针对人HLA - DR、HLA - DQ和HLA - DP分子上单一型决定簇的单克隆抗体来确定T细胞系的HLA限制性。MBP特异性T细胞系可以从MS患者和健康个体中以相当的效率分离出来。在两组中,MBP特异性T淋巴细胞识别MBP分子中至少4种不同的表位,并且针对不同MBP肽段的特异性呈现出相似的模式。源自MS患者和对照组的MBP特异性T细胞系受人类主要组织相容性复合体II类基因座的DR产物限制。两组之间的T细胞系存在显著的表型差异。从MS患者中分离出的细胞系主要表达CD3 + CD4 + CD8 - 表型,而一些对照细胞系中高达87%是CD3 + CD4 + CD8 + T淋巴细胞。这些发现表明,MS患者和对照组中存在对MBP同样敏感且受HLA - DR产物限制的MBP特异性T细胞。